Ruby Pelingon
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Phenothiazines and Benzothiazines Synthesis and Activities 2
- Inflammasome and immune disorders 2
- Glycosylation and Glycoproteins Research 1
-
- Antibiotic Resistance in Bacteria 4
- Co-authors
- Matthew A. Cooper (9 shared papers)Mark S. Butler (8 shared papers)Mark A. T. Blaskovich (6 shared papers)Alysha G. Elliott (3 shared papers)Johnny X. Huang (3 shared papers)Soumya Ramu (2 shared papers)Angela M. Kavanagh (2 shared papers)Wanida Phetsang (2 shared papers)
- Journals
- Journal of Medicinal Chemistry (2 papers)Analytical Biochemistry (1 paper)ChemMedChem (1 paper)European Journal of Medicinal Chemistry (1 paper)Antimicrobial Agents and Chemotherapy (1 paper)
- Partner nations
- AustraliaUnited StatesIreland
In The Last Decade
Ruby Pelingon
9 papers receiving 425 citations
Peers
Comparison fields: 5 of 69
- Molecular Medicine 142
- Applied Microbiology and Biotechnology 16
- Microbiology 45
- Pharmacology 93
- Biological Psychiatry 8
Countries citing papers authored by Ruby Pelingon
This map shows the geographic impact of Ruby Pelingon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruby Pelingon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruby Pelingon more than expected).
Fields of papers citing papers by Ruby Pelingon
This network shows the impact of papers produced by Ruby Pelingon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruby Pelingon. The network helps show where Ruby Pelingon may publish in the future.
Co-authors
The 25 scholars most cited alongside Ruby Pelingon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 102 | |
| 2 | 2015 | 91 | |
| 3 | 2016 | 50 | |
| 4 | 2017 | 49 | |
| 5 | 2016 | 45 | |
| 6 | 2016 | 41 | |
| 7 | 2019 | 32 | |
| 8 | 2018 | 22 | |
| 9 | 2020 | 4 | |
| 10 | 2025 | 0 |
About Ruby Pelingon
Ruby Pelingon is a scholar working on Molecular Biology, Molecular Medicine, Pharmacology, Physiology and Parasitology, having authored 10 papers that have together received 436 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (4 papers), Phenothiazines and Benzothiazines Synthesis and Activities (2 papers), Adenosine and Purinergic Signaling (2 papers), Inflammasome and immune disorders (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), Parasitic Infections and Diagnostics (2 papers), Parasites and Host Interactions (1 paper) and Glycosylation and Glycoproteins Research (1 paper). The work is most often cited by research in Molecular Medicine (142 citations), Applied Microbiology and Biotechnology (16 citations), Microbiology (45 citations), Pharmacology (93 citations) and Biological Psychiatry (8 citations). Ruby Pelingon has collaborated with scholars based in Australia, United States and Ireland. Frequent co-authors include Matthew A. Cooper, Mark S. Butler, Mark A. T. Blaskovich, Alysha G. Elliott, Johnny X. Huang, Soumya Ramu, Angela M. Kavanagh, Wanida Phetsang, Craig Muldoon and Alejandra Gallardo‐Godoy. Their work appears in journals such as Journal of Medicinal Chemistry, Analytical Biochemistry, ChemMedChem, European Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.